NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.
LEI: 213800VQ1PQHOJXDDQ88
15 February 2021
Baronsmead Venture Trust Plc
Update on Fundraising
On 17 September 2020 Baronsmead Venture Trust plc (the "Company") launched, in conjunction with Baronsmead Second Venture Trust plc, an offer for subscription (the "Offer") to each raise up to £20 million together with an over allotment facility to each raise up to a further £17.5 million (the "Over Allotment Facility").
Further to the announcement made by the Company on 6 January 2021, the Board have resolved to release a further £2.5 million of new shares under the Over Allotment Facility. The Board will continue to monitor the volume of subscriptions received from shareholders in relation to the Over Allotment Facility and the levels of investment activity and may release the remaining £5 million of new shares available under the Over Allotment Facility in due course.
Further information
For further information please contact:
Baronsmead VCT Investor Relations
020 3875 9862
baronsmeadvcts@greshamhouse.com
Notes
This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.
The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
